01 1BRISTOL
02 4GILEAD SCIENCES INC
03 10JANSSEN PRODS
01 158148374
01 15Y
01 15Y
01 152029-09-03
Patent Expiration Date : 2029-09-03
ATAZANAVIR SULFATE; COBICISTAT
US Patent Number : 8148374
Drug Substance Claim : Y
Drug Product Claim : Y
Application Number : 206353
Patent Use Code : U-1279
Delist Requested :
Patent Use Description : TREATMENT OF HIV INFEC...
Patent Expiration Date : 2029-09-03
Patent Expiration Date : 2029-09-03
COBICISTAT; ELVITEGRAVIR; EMTRICITABINE; TENOFOVIR ALAFENAMIDE FUMARATE
US Patent Number : 8148374
Drug Substance Claim : Y
Drug Product Claim : Y
Application Number : 207561
Patent Use Code : U-1279
Delist Requested :
Patent Use Description : TREATMENT OF HIV INFEC...
Patent Expiration Date : 2029-09-03
Patent Expiration Date : 2029-09-03
US Patent Number : 8148374
Drug Substance Claim : Y
Drug Product Claim : Y
Application Number : 203094
Patent Use Code : U-1279
Delist Requested :
Patent Use Description : TREATMENT OF HIV INFEC...
Patent Expiration Date : 2029-09-03
Patent Expiration Date : 2029-09-03
US Patent Number : 8148374
Drug Substance Claim : Y
Drug Product Claim : Y
Application Number : 203094
Patent Use Code : U-1279
Delist Requested :
Patent Use Description : TREATMENT OF HIV INFEC...
Patent Expiration Date : 2029-09-03
Patent Expiration Date : 2029-09-03
COBICISTAT; ELVITEGRAVIR; EMTRICITABINE; TENOFOVIR DISOPROXIL FUMARATE
US Patent Number : 8148374
Drug Substance Claim : Y
Drug Product Claim : Y
Application Number : 203100
Patent Use Code : U-1279
Delist Requested :
Patent Use Description : TREATMENT OF HIV INFEC...
Patent Expiration Date : 2029-09-03
Patent Expiration Date : 2029-09-03
COBICISTAT; DARUNAVIR ETHANOLATE
US Patent Number : 8148374
Drug Substance Claim : Y
Drug Product Claim : Y
Application Number : 205395
Patent Use Code : U-4162
Delist Requested :
Patent Use Description :
Patent Expiration Date : 2029-09-03
Patent Expiration Date : 2029-09-03
COBICISTAT; DARUNAVIR; EMTRICITABINE; TENOFOVIR ALAFENAMIDE FUMARATE
US Patent Number : 8148374
Drug Substance Claim : Y
Drug Product Claim : Y
Application Number : 210455
Patent Use Code : U-2766
Delist Requested :
Patent Use Description :
Patent Expiration Date : 2029-09-03
Patent Expiration Date : 2029-09-03
COBICISTAT; DARUNAVIR; EMTRICITABINE; TENOFOVIR ALAFENAMIDE FUMARATE
US Patent Number : 8148374
Drug Substance Claim : Y
Drug Product Claim : Y
Application Number : 210455
Patent Use Code : U-2365
Delist Requested :
Patent Use Description :
Patent Expiration Date : 2029-09-03
Patent Expiration Date : 2029-09-03
COBICISTAT; DARUNAVIR; EMTRICITABINE; TENOFOVIR ALAFENAMIDE FUMARATE
US Patent Number : 8148374
Drug Substance Claim : Y
Drug Product Claim : Y
Application Number : 210455
Patent Use Code : U-2768
Delist Requested :
Patent Use Description :
Patent Expiration Date : 2029-09-03
Patent Expiration Date : 2029-09-03
COBICISTAT; DARUNAVIR; EMTRICITABINE; TENOFOVIR ALAFENAMIDE FUMARATE
US Patent Number : 8148374
Drug Substance Claim : Y
Drug Product Claim : Y
Application Number : 210455
Patent Use Code : U-2364
Delist Requested :
Patent Use Description :
Patent Expiration Date : 2029-09-03
